Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 209.6M 21.66M 2023-09
Agios Pharmaceuticals USD 58.42M 3.28M 2023-09
Alnylam Pharmaceuticals USD 949.78M 161.15M 2023-09
Arrowhead Research USD 105.46M 35.23M 2023-09
AstraZeneca USD 28.59B 2.21B 2023-09
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Enanta Pharmaceuticals USD 62.79M 5.4M 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Halozyme Therapeutics USD 115.18M 1.21M 2023-09
Heron Therapeutics USD 79.74M 6.98M 2023-09
Insmed USD 196.73M 7.53M 2023-09
Ligand Pharmaceuticals USD 18.87M 10.52M 2023-09
Minerva Neurosciences USD 3.35M 1.44M 2023-09
Moderna USD 4.39B 1.26B 2023-09
PTC Therapeutics USD 492.12M 15.78M 2023-09
Takeda JPY 2.37T 134.12B 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vanda Pharmaceuticals USD 87.4M 6.4M 2023-06
Veracyte USD 57.26M 891K 2023-09



Vanda Pharmaceuticals Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.